Sopan Pharmaceuticals to issue IPO on March 23

Mar 13, 2026 12:07 PM Merolagani



Sopan Pharmaceuticals is set to issue initial public offering (IPO) to foreign migrated workers on March 23.

The company obtained approval to issue 25 percent of ordinary shares of its issued capital of Rs 1.71 billion. Accoridngly, it will issue 4,290,000 units of shares worth Rs 429 million to the general public.

Out of total approved units, the company is issuing 429,000 units of shares worth Rs 42.9 million to foreign migrated workers.

Moreover, the company has secured 214,500 units to mutual funds and 171,600 units to employees. The remaining 3,474,900 units will be issued later to the general public.

Interested investors can apply for a minimum of 10 units and maximum of 11,000 units of shares. The issue will close early on March 26 and lately on April 9.

The company has appointed NMB Capital as issue manager. The interested investors can apply from all C-ASBA approved BFIs and Meroshare.

Care Ratings Nepal has assigned B rating to the issuer indicating high risks.

 




Gold and Silver Price Increase

Mar 08, 2026 10:42 AM

The gold and silver price have increased on March 8.

Sudhan Gurung Leading in Gorkha-1

Mar 08, 2026 08:30 AM

Gold and Silver Price Decrease

Mar 09, 2026 10:52 AM

Gold and Silver Price Decline

Mar 12, 2026 10:58 AM